These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 726023)

  • 1. Factor VIII procoagulant and antigen content of antihemophilic factor (AHF) concentrates.
    Yang HC; Duffy C
    Transfusion; 1978; 18(6):747-9. PubMed ID: 726023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of variability in antihemophilic factor (factor VIII) procoagulant titers and precipitating antigen levels among obligate carriers of classic hemophilia.
    Jones PK; Ratnoff OD
    Blood; 1981 May; 57(5):928-32. PubMed ID: 6783148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient deficiency of antihemophilic factor (AHF) procoagulant and AHF-like antigen during administration of tetracycline.
    Stefanini M
    Am J Clin Pathol; 1980 Mar; 73(3):439-43. PubMed ID: 7361727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII-related activities in therapeutic concentrates.
    Barrowcliffe TW; Kemball-Cook G; Morris G; Holt JC; Furlong RA; Peake IR
    J Lab Clin Med; 1981 Mar; 97(3):429-38. PubMed ID: 6780643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoradiometric measurement of the factor VIII procoagulant antigen.
    Lazarchick J; Hoyer LW
    J Clin Invest; 1978 Nov; 62(5):1048-52. PubMed ID: 81838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihemophilic factor concentrate therapy in von Willebrand disease. Dissociation of bleeding-time factor and ristocetin-cofactor activities.
    Blatt PM; Brinkhous KM; Culp HR; Krauss JS; Roberts HR
    JAMA; 1976 Dec; 236(24):2770-2. PubMed ID: 1086910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver.
    Green AJ; Ratnoff OD
    J Lab Clin Med; 1974 Feb; 83(2):189-97. PubMed ID: 4204243
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor VIII concentrates contain factor VIII procoagulant antigen bound to phospholipid.
    Kemball-Cook G; Barrowcliffe TW
    Br J Haematol; 1986 Jul; 63(3):425-34. PubMed ID: 3089269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII procoagulant antigen recovery is a dose-related response to Factor VIII concentrate infusions.
    Taylor L; Ekert H; Dean F
    Haemostasis; 1984; 14(4):296-301. PubMed ID: 6437942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus RNA in factor VIII concentrates.
    Guo ZP; Yu MW
    Transfusion; 1995 Feb; 35(2):112-6. PubMed ID: 7825205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 'in vivo' survival characteristics of factor VIII procoagulant antigen (VIII:C Ag) in haemophilia A subjects.
    McLellan DS; Pelly C; McLellan HG; Jones P; Aronstam A
    Thromb Res; 1982 Jan 1-15; 25(1-2):33-9. PubMed ID: 6801811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of VIII AHF response to adrenalin in hemophilia A.
    Eyster ME; Dranchak M; Haverstick J; Rogers JS
    Am J Hematol; 1977; 3():193-8. PubMed ID: 602937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine-precipitated antihemophilic factor concentrates and their clinical use.
    Wagner RH; Roberts HR; Webster WP; Shanbrom E; Brinkhous KM
    Thromb Diath Haemorrh Suppl; 1968; 35():41-8. PubMed ID: 5761073
    [No Abstract]   [Full Text] [Related]  

  • 18. Causes for the discrepancies in the measurements of factor VIII antigen.
    Howard MA; Hau L; Perkin J; Thomas KB; Firkin BG; Koutts J
    Thromb Res; 1980 Jul 1-15; 19(1-2):63-72. PubMed ID: 6777892
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoradiometric assay of procoagulant factor VIII antigen (VIIICAG).
    Muller HP; van Tilburg NH; Bertina RM; Terwiel JP; Veltkamp JJ
    Clin Chim Acta; 1980 Oct; 107(1-2):11-9. PubMed ID: 6775848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of antihemophilic factor antigen by cultured human endothelial cells.
    Jaffe EA; Hoyer LW; Nachman RL
    J Clin Invest; 1973 Nov; 52(11):2757-64. PubMed ID: 4583980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.